Trijardy XR

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0597-0385
  • Package NDC 0597-0385-77
  • Package NDC 0597-0385-86
  • Application number NDA212614
  • SPL ID 40d8f12b-47be-4a48-be56-9cd025ac63d4
  • SPL set ID 71873567-9594-452a-bb92-34a129adecac
  • UNII 3X29ZEJ4R2
  • UNII HDC1R2M35U
  • UNII 786Z46389E
  • RxCUI 2359279
  • RxCUI 2359285
  • RxCUI 2359288
  • RxCUI 2359290
  • RxCUI 2359351
  • RxCUI 2359353
  • RxCUI 2359356
  • RxCUI 2359358

What the source publishes

Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Active ingredients
empagliflozin, linagliptin, metformin hydrochloride
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0597-0385_40d8f12b-47be-4a48-be56-9cd025ac63d4
{
  "name": "Trijardy XR",
  "splId": "40d8f12b-47be-4a48-be56-9cd025ac63d4",
  "labels": [
    {
      "setId": "71873567-9594-452a-bb92-34a129adecac",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71873567-9594-452a-bb92-34a129adecac",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=71873567-9594-452a-bb92-34a129adecac"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Boehringer Ingelheim Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-77)",
      "package_ndc": "0597-0385-77",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200423"
    },
    {
      "sample": false,
      "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86)",
      "package_ndc": "0597-0385-86",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200423"
    }
  ],
  "productId": "0597-0385_40d8f12b-47be-4a48-be56-9cd025ac63d4",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "0597-0385",
  "deaSchedule": null,
  "genericName": "empagliflozin, linagliptin, metformin hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "EMPAGLIFLOZIN",
      "strength": "12.5 mg/1"
    },
    {
      "name": "LINAGLIPTIN",
      "strength": "2.5 mg/1"
    },
    {
      "name": "METFORMIN HYDROCHLORIDE",
      "strength": "1000 mg/1"
    }
  ],
  "applicationNumber": "NDA212614",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200423",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175912",
      "N0000175913",
      "N0000187059",
      "N0000187058"
    ],
    "unii": [
      "3X29ZEJ4R2",
      "HDC1R2M35U",
      "786Z46389E"
    ],
    "rxcui": [
      "2359279",
      "2359285",
      "2359288",
      "2359290",
      "2359351",
      "2359353",
      "2359356",
      "2359358"
    ],
    "spl_set_id": [
      "71873567-9594-452a-bb92-34a129adecac"
    ],
    "pharm_class_epc": [
      "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
      "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Boehringer Ingelheim Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0597-0385_40d8f12b-47be-4a48-be56-9cd025ac63d4"